Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment

Qing Ke, Zheng Yan Zhao, Robert Griggs, Veronica Wiley, Anne Connolly, Jennifer Kwon, Ming Qi, Daniel Sheehan, Emma Ciafaloni, R. Rodney Howell, Petra Furu, Peter Sazani, Arvind Narayana, Michele Gatheridge

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: Newborn screening for Duchenne muscular dystrophy (DMD) is currently being initiated in Zhejiang Province, China and is under consideration in other countries, including the United States. As China begins to implement DMD newborn screening (DMD-NBS), there is ongoing discussion regarding the steps forward for follow up care of positively identified patients as well as false positive and false negative results. Data sources: Relevant papers related to DMD-NBS, and NBS in China were reviewed in PubMed. Results: The current state of DMD-NBS is discussed, along with the steps needed to effectively screen infants for this disease in China, recommendations for establishment of follow up care in patients with positive and negative screens, and measurement of patient outcomes. Conclusions: Zhejiang Province, China is ready to implement DMD-NBS. Future challenges that exist for this program, and other countries, include the ability to track patients, assist with access to care, and ensure adequate follow-up care according to evidence-based guidelines. In addition, China’s large rural population, lack of specialty providers, and difficulty in educating patients regarding the benefits of treatment create challenges that will need to be addressed.

Original languageEnglish (US)
Pages (from-to)197-201
Number of pages5
JournalWorld Journal of Pediatrics
Volume13
Issue number3
DOIs
StatePublished - Jun 1 2017

Fingerprint

Duchenne Muscular Dystrophy
China
Newborn Infant
Aftercare
Therapeutics
Information Storage and Retrieval
Rural Population
PubMed
Guidelines

Keywords

  • Duchene muscular dystrophy
  • neurology
  • neuromuscular disorders
  • newborn screening

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Ke, Q., Zhao, Z. Y., Griggs, R., Wiley, V., Connolly, A., Kwon, J., ... Gatheridge, M. (2017). Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment. World Journal of Pediatrics, 13(3), 197-201. https://doi.org/10.1007/s12519-017-0036-3

Newborn screening for Duchenne muscular dystrophy in China : follow-up diagnosis and subsequent treatment. / Ke, Qing; Zhao, Zheng Yan; Griggs, Robert; Wiley, Veronica; Connolly, Anne; Kwon, Jennifer; Qi, Ming; Sheehan, Daniel; Ciafaloni, Emma; Howell, R. Rodney; Furu, Petra; Sazani, Peter; Narayana, Arvind; Gatheridge, Michele.

In: World Journal of Pediatrics, Vol. 13, No. 3, 01.06.2017, p. 197-201.

Research output: Contribution to journalReview article

Ke, Q, Zhao, ZY, Griggs, R, Wiley, V, Connolly, A, Kwon, J, Qi, M, Sheehan, D, Ciafaloni, E, Howell, RR, Furu, P, Sazani, P, Narayana, A & Gatheridge, M 2017, 'Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment', World Journal of Pediatrics, vol. 13, no. 3, pp. 197-201. https://doi.org/10.1007/s12519-017-0036-3
Ke, Qing ; Zhao, Zheng Yan ; Griggs, Robert ; Wiley, Veronica ; Connolly, Anne ; Kwon, Jennifer ; Qi, Ming ; Sheehan, Daniel ; Ciafaloni, Emma ; Howell, R. Rodney ; Furu, Petra ; Sazani, Peter ; Narayana, Arvind ; Gatheridge, Michele. / Newborn screening for Duchenne muscular dystrophy in China : follow-up diagnosis and subsequent treatment. In: World Journal of Pediatrics. 2017 ; Vol. 13, No. 3. pp. 197-201.
@article{5e6b997ed2b74308adc9834c57867ce9,
title = "Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment",
abstract = "Background: Newborn screening for Duchenne muscular dystrophy (DMD) is currently being initiated in Zhejiang Province, China and is under consideration in other countries, including the United States. As China begins to implement DMD newborn screening (DMD-NBS), there is ongoing discussion regarding the steps forward for follow up care of positively identified patients as well as false positive and false negative results. Data sources: Relevant papers related to DMD-NBS, and NBS in China were reviewed in PubMed. Results: The current state of DMD-NBS is discussed, along with the steps needed to effectively screen infants for this disease in China, recommendations for establishment of follow up care in patients with positive and negative screens, and measurement of patient outcomes. Conclusions: Zhejiang Province, China is ready to implement DMD-NBS. Future challenges that exist for this program, and other countries, include the ability to track patients, assist with access to care, and ensure adequate follow-up care according to evidence-based guidelines. In addition, China’s large rural population, lack of specialty providers, and difficulty in educating patients regarding the benefits of treatment create challenges that will need to be addressed.",
keywords = "Duchene muscular dystrophy, neurology, neuromuscular disorders, newborn screening",
author = "Qing Ke and Zhao, {Zheng Yan} and Robert Griggs and Veronica Wiley and Anne Connolly and Jennifer Kwon and Ming Qi and Daniel Sheehan and Emma Ciafaloni and Howell, {R. Rodney} and Petra Furu and Peter Sazani and Arvind Narayana and Michele Gatheridge",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s12519-017-0036-3",
language = "English (US)",
volume = "13",
pages = "197--201",
journal = "World Journal of Pediatrics",
issn = "1708-8569",
publisher = "Institute of Pediatrics of Zhejiang University",
number = "3",

}

TY - JOUR

T1 - Newborn screening for Duchenne muscular dystrophy in China

T2 - follow-up diagnosis and subsequent treatment

AU - Ke, Qing

AU - Zhao, Zheng Yan

AU - Griggs, Robert

AU - Wiley, Veronica

AU - Connolly, Anne

AU - Kwon, Jennifer

AU - Qi, Ming

AU - Sheehan, Daniel

AU - Ciafaloni, Emma

AU - Howell, R. Rodney

AU - Furu, Petra

AU - Sazani, Peter

AU - Narayana, Arvind

AU - Gatheridge, Michele

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background: Newborn screening for Duchenne muscular dystrophy (DMD) is currently being initiated in Zhejiang Province, China and is under consideration in other countries, including the United States. As China begins to implement DMD newborn screening (DMD-NBS), there is ongoing discussion regarding the steps forward for follow up care of positively identified patients as well as false positive and false negative results. Data sources: Relevant papers related to DMD-NBS, and NBS in China were reviewed in PubMed. Results: The current state of DMD-NBS is discussed, along with the steps needed to effectively screen infants for this disease in China, recommendations for establishment of follow up care in patients with positive and negative screens, and measurement of patient outcomes. Conclusions: Zhejiang Province, China is ready to implement DMD-NBS. Future challenges that exist for this program, and other countries, include the ability to track patients, assist with access to care, and ensure adequate follow-up care according to evidence-based guidelines. In addition, China’s large rural population, lack of specialty providers, and difficulty in educating patients regarding the benefits of treatment create challenges that will need to be addressed.

AB - Background: Newborn screening for Duchenne muscular dystrophy (DMD) is currently being initiated in Zhejiang Province, China and is under consideration in other countries, including the United States. As China begins to implement DMD newborn screening (DMD-NBS), there is ongoing discussion regarding the steps forward for follow up care of positively identified patients as well as false positive and false negative results. Data sources: Relevant papers related to DMD-NBS, and NBS in China were reviewed in PubMed. Results: The current state of DMD-NBS is discussed, along with the steps needed to effectively screen infants for this disease in China, recommendations for establishment of follow up care in patients with positive and negative screens, and measurement of patient outcomes. Conclusions: Zhejiang Province, China is ready to implement DMD-NBS. Future challenges that exist for this program, and other countries, include the ability to track patients, assist with access to care, and ensure adequate follow-up care according to evidence-based guidelines. In addition, China’s large rural population, lack of specialty providers, and difficulty in educating patients regarding the benefits of treatment create challenges that will need to be addressed.

KW - Duchene muscular dystrophy

KW - neurology

KW - neuromuscular disorders

KW - newborn screening

UR - http://www.scopus.com/inward/record.url?scp=85018392251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018392251&partnerID=8YFLogxK

U2 - 10.1007/s12519-017-0036-3

DO - 10.1007/s12519-017-0036-3

M3 - Review article

C2 - 28466241

AN - SCOPUS:85018392251

VL - 13

SP - 197

EP - 201

JO - World Journal of Pediatrics

JF - World Journal of Pediatrics

SN - 1708-8569

IS - 3

ER -